The Direct and Indirect Cost Burden of Crohn's Disease and Ulcerative Colitis

被引：138

作者：

Gibson, Teresa B. ^{[1
]}

Ng, Eliza

Ozminkowski, Ronald J.

Wang, Shaohung ^{[3
]}

Burton, Wayne N. ^{[4
]}

Goetzel, Ron Z. ^{[5
,6
]}

Maclean, Ross ^{[2
]}

机构：

[1] Thomson Healthcare, Div Res, Ann Arbor, MI 48108 USA

[2] Bristol Myers Squibb Co, Global Outcomes Res Strategy, Princeton, NJ USA

[3] Thomson Healthcare, Div Res, Cambridge, MA USA

[4] Univ Illinois, Chicago, IL USA

[5] Emory Univ, Rollins Sch Publ Hlth, Inst Hlth & Product Studies, Washington, DC USA

[6] Thomson Healthcare, Div Res, Washington, DC USA

来源：

JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE | 2008年 / 50卷 / 11期

关键词：

D O I：

10.1097/JOM.0b013e318181b8ca

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Objective: To estimate the direct medical and indirect (absenteeism and short-term disability) cost burden of Crohn's Disease (CD) rind Ulcerative Colitis (UC). Methods: Data were obtained from 1999 to 2005 MarketScan databases. Twelve-month expenditures for patients with CD and UC were compared to expenditures among an. equal number of propensity score matched comparison group patients. Regression analysis controlled for demographics and case-mix. Results: Annual medical expenditures were significantly higher for commercially insured CD and UC patients compared to matched comparison group patients ($18,963 vs $5300 for CD patients, $15,020 vs $4982 for UC patients, respectively, all P < 0.001). Indirect costs were also high for employed patients with these conditions. Conclusions: CD and UC are costly diseases with a signficant cost burden related to health care utilization and productivity loss. (J Occup Environ Med. 2008;50: 1261-1272)

引用

页码：1261 / 1272

页数：12

共 42 条

[1]

ALPER BS, 2007, DYNAMED CROHNS DIS C

[2]

ALPER BS, 2007, DYNAMED ULCERATIVE C

[3] A PSYCHIATRIC-PATIENT CLASSIFICATION-SYSTEM - AN ALTERNATIVE TO DIAGNOSIS-RELATED GROUPS [J].

ASHCRAFT, MLF ;

FRIES, BE ;

NERENZ, DR ;

FALCON, SP ;

SRIVASTAVA, SV ;

LEE, CZ ;

BERKI, SE ;

ERRERA, P .

MEDICAL CARE, 1989, 27 (05) :543-557

[4] Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study [J].

Bassi, A ;

Dodd, S ;

Williamson, P ;

Bodger, K .

GUT, 2004, 53 (10) :1471-1478

[5] Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease [J].

Bernklev, T ;

Jahnsen, J ;

Henriksen, M ;

Lygren, I ;

Aadland, E ;

Sauar, J ;

Schulz, T ;

Stray, N ;

Vatn, M ;

Moum, B .

INFLAMMATORY BOWEL DISEASES, 2006, 12 (05) :402-412

[6] Hospitalization, surgery, and readmission rates of IBD in Canada: A population-based study [J].

Bernstein, CN ;

Nabalamba, A .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (01) :110-118

[7] Inflammatory bowel diseases: Health care and costs in Sweden in 1994 [J].

Blomqvist, P ;

Ekbom, A .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1997, 32 (11) :1134-1139

[8] Cost of illness of Crohn's disease [J].

Bodger, K .

PHARMACOECONOMICS, 2002, 20 (10) :639-652

[9] The impact of inflammatory bowel disease on labor force participation:: Results of a population sampled case-control study [J].

Boonen, A ;

Dagnelie, PC ;

Feleus, A ;

Hesselink, MA ;

Muris, JW ;

Stockbrügger, RW ;

Russel, MG .

INFLAMMATORY BOWEL DISEASES, 2002, 8 (06) :382-389

[10]

Cohen RD, 2000, AM J GASTROENTEROL, V95, P524

← 1 2 3 4 5 →